Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT

Erythropoietin receptor (EPOR) is widely expressed in healthy and malignant tissues. In certain malignancies, EPOR stimulates tumor growth. In healthy tissues, EPOR controls processes other than erythropoiesis, including mitochondrial metabolism. We hypothesized that EPOR also controls the mitochond...

Full description

Bibliographic Details
Main Authors: Mostafa A. Aboouf, Franco Guscetti, Nadine von Büren, Julia Armbruster, Hyrije Ademi, Maja Ruetten, Florinda Meléndez-Rodríguez, Thomas Rülicke, Alexander Seymer, Robert A. Jacobs, Edith M. Schneider Gasser, Julian Aragones, Drorit Neumann, Max Gassmann, Markus Thiersch
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.976961/full
_version_ 1811215184389210112
author Mostafa A. Aboouf
Mostafa A. Aboouf
Mostafa A. Aboouf
Mostafa A. Aboouf
Franco Guscetti
Nadine von Büren
Nadine von Büren
Julia Armbruster
Julia Armbruster
Hyrije Ademi
Hyrije Ademi
Maja Ruetten
Florinda Meléndez-Rodríguez
Thomas Rülicke
Alexander Seymer
Robert A. Jacobs
Edith M. Schneider Gasser
Edith M. Schneider Gasser
Julian Aragones
Drorit Neumann
Max Gassmann
Max Gassmann
Markus Thiersch
Markus Thiersch
Markus Thiersch
author_facet Mostafa A. Aboouf
Mostafa A. Aboouf
Mostafa A. Aboouf
Mostafa A. Aboouf
Franco Guscetti
Nadine von Büren
Nadine von Büren
Julia Armbruster
Julia Armbruster
Hyrije Ademi
Hyrije Ademi
Maja Ruetten
Florinda Meléndez-Rodríguez
Thomas Rülicke
Alexander Seymer
Robert A. Jacobs
Edith M. Schneider Gasser
Edith M. Schneider Gasser
Julian Aragones
Drorit Neumann
Max Gassmann
Max Gassmann
Markus Thiersch
Markus Thiersch
Markus Thiersch
author_sort Mostafa A. Aboouf
collection DOAJ
description Erythropoietin receptor (EPOR) is widely expressed in healthy and malignant tissues. In certain malignancies, EPOR stimulates tumor growth. In healthy tissues, EPOR controls processes other than erythropoiesis, including mitochondrial metabolism. We hypothesized that EPOR also controls the mitochondrial metabolism in cancer cells. To test this hypothesis, we generated EPOR-knockdown cancer cells to grow tumor xenografts in mice and analyzed tumor cellular respiration via high-resolution respirometry. Furthermore, we analyzed cellular respiratory control, mitochondrial content, and regulators of mitochondrial biogenesis in vivo and in vitro in different cancer cell lines. Our results show that EPOR controls tumor growth and mitochondrial biogenesis in tumors by controlling the levels of both, pAKT and inducible NO synthase (iNOS). Furthermore, we observed that the expression of EPOR is associated with the expression of the mitochondrial marker VDAC1 in tissue arrays of lung cancer patients, suggesting that EPOR indeed helps to regulate mitochondrial biogenesis in tumors of cancer patients. Thus, our data imply that EPOR not only stimulates tumor growth but also regulates tumor metabolism and is a target for direct intervention against progression.
first_indexed 2024-04-12T06:17:51Z
format Article
id doaj.art-310af4056b6044878b44d59abc419570
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T06:17:51Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-310af4056b6044878b44d59abc4195702022-12-22T03:44:25ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.976961976961Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKTMostafa A. Aboouf0Mostafa A. Aboouf1Mostafa A. Aboouf2Mostafa A. Aboouf3Franco Guscetti4Nadine von Büren5Nadine von Büren6Julia Armbruster7Julia Armbruster8Hyrije Ademi9Hyrije Ademi10Maja Ruetten11Florinda Meléndez-Rodríguez12Thomas Rülicke13Alexander Seymer14Robert A. Jacobs15Edith M. Schneider Gasser16Edith M. Schneider Gasser17Julian Aragones18Drorit Neumann19Max Gassmann20Max Gassmann21Markus Thiersch22Markus Thiersch23Markus Thiersch24Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandZurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, SwitzerlandCenter for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandDepartment of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, EgyptInstitute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandCenter for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandCenter for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandCenter for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandPathoVet AG, Pathology Diagnostic Laboratory, Tagelswangen, SwitzerlandHospital Universitario Santa Cristina, Autonomous University of Madrid, Madrid, SpainDepartment of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, AustriaDepartment for Sociology and Social Geography, Paris Lodron University of Salzburg (PLUS), Salzburg, Austria0Department of Human Physiology & Nutrition, University of Colorado Colorado Springs (UCCS), Colorado Springs, CO, United StatesInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland1Center of Neuroscience Zurich (ZNZ), University of Zurich, Zurich, SwitzerlandHospital Universitario Santa Cristina, Autonomous University of Madrid, Madrid, Spain2Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, IsraelInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandZurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, SwitzerlandInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandZurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, SwitzerlandCenter for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, SwitzerlandErythropoietin receptor (EPOR) is widely expressed in healthy and malignant tissues. In certain malignancies, EPOR stimulates tumor growth. In healthy tissues, EPOR controls processes other than erythropoiesis, including mitochondrial metabolism. We hypothesized that EPOR also controls the mitochondrial metabolism in cancer cells. To test this hypothesis, we generated EPOR-knockdown cancer cells to grow tumor xenografts in mice and analyzed tumor cellular respiration via high-resolution respirometry. Furthermore, we analyzed cellular respiratory control, mitochondrial content, and regulators of mitochondrial biogenesis in vivo and in vitro in different cancer cell lines. Our results show that EPOR controls tumor growth and mitochondrial biogenesis in tumors by controlling the levels of both, pAKT and inducible NO synthase (iNOS). Furthermore, we observed that the expression of EPOR is associated with the expression of the mitochondrial marker VDAC1 in tissue arrays of lung cancer patients, suggesting that EPOR indeed helps to regulate mitochondrial biogenesis in tumors of cancer patients. Thus, our data imply that EPOR not only stimulates tumor growth but also regulates tumor metabolism and is a target for direct intervention against progression.https://www.frontiersin.org/articles/10.3389/fonc.2022.976961/fullerythropoietin receptortumor metabolismmitochondrial biogenesisnitric oxide (NO)respirometryOXPHOS
spellingShingle Mostafa A. Aboouf
Mostafa A. Aboouf
Mostafa A. Aboouf
Mostafa A. Aboouf
Franco Guscetti
Nadine von Büren
Nadine von Büren
Julia Armbruster
Julia Armbruster
Hyrije Ademi
Hyrije Ademi
Maja Ruetten
Florinda Meléndez-Rodríguez
Thomas Rülicke
Alexander Seymer
Robert A. Jacobs
Edith M. Schneider Gasser
Edith M. Schneider Gasser
Julian Aragones
Drorit Neumann
Max Gassmann
Max Gassmann
Markus Thiersch
Markus Thiersch
Markus Thiersch
Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
Frontiers in Oncology
erythropoietin receptor
tumor metabolism
mitochondrial biogenesis
nitric oxide (NO)
respirometry
OXPHOS
title Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
title_full Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
title_fullStr Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
title_full_unstemmed Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
title_short Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT
title_sort erythropoietin receptor regulates tumor mitochondrial biogenesis through inos and pakt
topic erythropoietin receptor
tumor metabolism
mitochondrial biogenesis
nitric oxide (NO)
respirometry
OXPHOS
url https://www.frontiersin.org/articles/10.3389/fonc.2022.976961/full
work_keys_str_mv AT mostafaaaboouf erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT mostafaaaboouf erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT mostafaaaboouf erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT mostafaaaboouf erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT francoguscetti erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT nadinevonburen erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT nadinevonburen erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT juliaarmbruster erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT juliaarmbruster erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT hyrijeademi erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT hyrijeademi erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT majaruetten erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT florindamelendezrodriguez erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT thomasrulicke erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT alexanderseymer erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT robertajacobs erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT edithmschneidergasser erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT edithmschneidergasser erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT julianaragones erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT droritneumann erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT maxgassmann erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT maxgassmann erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT markusthiersch erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT markusthiersch erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt
AT markusthiersch erythropoietinreceptorregulatestumormitochondrialbiogenesisthroughinosandpakt